Therapeutic Synergism of Hyperthermia-cis-Platinum in a Mouse Tumor Model23
Open Access
- 1 August 1980
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 65 (2) , 455-461
- https://doi.org/10.1093/jnci/65.2.455
Abstract
A small-animal model was developed as a guide to whole-body hyperthermia in cancer patients. Anesthetized DBA/2 mice were secured to a platform, and their hindlimbs were immersed in a 42.3° C water bath for 30–60 minutes. Hindlimb hyperthermia resulted in steady-state rectal and femoral bone marrow and muscle temperatures of 42° C and upper extremity muscle and esophagus temperatures of 41° C. With this hyperthermia technique, the mouse spleen colony assay could be used to quantitate the lethality of hyperthermia and/or cis-dichlorodiammineplatinum(II) (cis-platinum) on clonogenic bone marrow and leukemia cells. Hyperthermia prior to cis-platinum administration increased cis-platinum inhibition of leukemia colony formation as much as 2 logs; however, antileukemia synergism was greatest when cis-platinum administration immediately preceded hyperthermia and no evidence existed of synergism against normal bone marrow colonies. Correlative in vivo drug uptake studies showed a marked increase in leukemia cell uptake of 195mPt-cis-platinum at elevated temperatures, which suggested a potential mechanism for the apparent antileukemia synergism of cis-platinum and heat.Keywords
This publication has 6 references indexed in Scilit:
- ENHANCEMENT BY HYPERTHERMIA OF EFFECT OF BCNU AGAINST EMT6 MOUSE TUMOR1978
- CIS-DICHLORODIAMMINEPLATINUM (II) IN TREATMENT OF EPIDERMOID CARCINOMA OF HEAD AND NECK1977
- Cytotoxic Effects of Hyperthermia and Adriamycin on Chinese Hamster Cells2JNCI Journal of the National Cancer Institute, 1976
- Changes in Mouse Blood Pressure, Tumor Blood Flow, and Core and Tumor Temperatures following Nembutal or Urethane AnesthesiaRadiology, 1976
- EFFECT OF PHENOBARBITAL ON CYCLOPHOSPHAMIDE ANTITUMOR ACTIVITY1976
- PHASE-2 STUDY OF CIS-DICHLORODIAMMINEPLATINUM(II) (NSC-119875) IN ADVANCED ADENOCARCINOMA OF OVARY1976